… had a dose-escalation design, meaning that the 600 mg dose … data of the 225-mg dose.
Patients remained in the clinical … anti-SARS-CoV-2 neutralizing activity and anti-SARS-CoV-2 …

… of first and second doses of approved SARS-CoV-2 vaccines (… days after receipt of the
second dose; partially vaccinated if the … escalation in risk to public health during the SARS-CoV-2 …

… We conducted a randomized, double-blind, placebo-controlled, single-dose, dose-escalation
Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), and …

… SARS-CoV-2 was recorded until day 29 with single doses from 2 to 20 mg/kg and until day
43 with two doses … rhesus macaque SARS-CoV-2 models, AOD01, at a single dose of 20 mg/…

… We performed a randomized, placebo-controlled Phase I trial with an unblinded dose
escalation and a double-blind treatment phase at 2 sites in France and Belgium to evaluate the …

… to receive 3 doses of 5 μg or 10 μg of a SARS-CoV-2 inactivated vaccine, or placebo separated
by 28 days. Adverse events (AEs) were recorded through day 28 after each dosing. Live …

… doses (3 μg and 6 μg) in a dose-escalation study with a two-… to live SARS-CoV-2 at day 28
after the second dose. … titre (GMT) of neutralising antibodies to live SARS-CoV-2, as well as …

… , patients endure escalating symptoms and without … dosage for bamlanivimab is a single
IV infusion of 700 mg administered as soon as possible after positive viral test for SARS-CoV-2 …

… We evaluate the effects of dose escalation and … Our vaccine induces high levels of SARS-CoV-2
neutralizing … immunity against SARS-CoV-2 variants after only a single dose. Together, …

… Multiple vaccines to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
The animals were challenged with SARS-CoV-2 on day 28 (one-dose group) and day 56 (…